ONCAlert | 2017 San Antonio Breast Cancer Symposium

The Potential of Immunotherapy in TNBC

Elizabeth A. Mittendorf, MD, PhD
Published Online:9:50 AM, Wed May 3, 2017

Elizabeth A. Mittendorf, MD, PhD, associate professor, department of surgical oncology, University of Texas MD Anderson Cancer Center, discusses the promise immunotherapy has shown thus far in breast cancer, particularly triple-negative breast cancer (TNBC). 
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.